3959 results in Medico-Legal, Bioethics and Health Law
Introduction to Part I
- from Part I - Transparency in Health and Health Care: Thematic Issues
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 15-16
-
- Chapter
- Export citation
23 - Using Disclosure to Regulate PBMs
- from Part VI - Challenges in Promoting and Measuring Transparency in Health Care
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 343-356
-
- Chapter
- Export citation
19 - Transparency Challenges in Reproductive Health Care
- from Part V - Transparency and Outcomes: Promoting Health and Safety
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 286-296
-
- Chapter
- Export citation
Transparency in Health and Health Care in the United States
- Law and Ethics
-
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019
Contributors
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp xi-xiv
-
- Chapter
- Export citation
10 - Price Transparency
- from Part III - Transparency and Economics: Health Care Costs and Billing
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 153-164
-
- Chapter
- Export citation
4 - Slightly Hazy
- from Part I - Transparency in Health and Health Care: Thematic Issues
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 58-68
-
- Chapter
- Export citation
Introduction to Part IV
- from Part IV - Transparency and Innovation
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 181-184
-
- Chapter
- Export citation
8 - Transparency on Prescription Drug Research Expenditures
- from Part III - Transparency and Economics: Health Care Costs and Billing
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 121-131
-
- Chapter
- Export citation
1 - Smashing into Windows
- from Part I - Transparency in Health and Health Care: Thematic Issues
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 17-29
-
- Chapter
- Export citation
20 - ERISA as a Barrier for State Health Care Transparency Efforts
- from Part VI - Challenges in Promoting and Measuring Transparency in Health Care
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 301-313
-
- Chapter
- Export citation
Copyright page
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp iv-iv
-
- Chapter
- Export citation
21 - Transparency and Data Sharing in Clinical Research and Big Pharma
- from Part VI - Challenges in Promoting and Measuring Transparency in Health Care
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 314-328
-
- Chapter
- Export citation
Part VI - Challenges in Promoting and Measuring Transparency in Health Care
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 297-298
-
- Chapter
- Export citation
Part III - Transparency and Economics: Health Care Costs and Billing
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 115-178
-
- Chapter
- Export citation
Appendix 2 - Rite Aid Generic Prices
- from 9 - Is Pharmaceutical Price Transparency an Effective Means to Reduce High Prices and Wide Variations?
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 151-152
-
- Chapter
- Export citation
18 - Nontransparency in Electronic Health Record Systems
- from Part V - Transparency and Outcomes: Promoting Health and Safety
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 273-285
-
- Chapter
- Export citation
6 - Transparency and Financial Conflicts
- from Part II - Transparency and Informed Consent
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 88-102
-
- Chapter
- Export citation
9 - Is Pharmaceutical Price Transparency an Effective Means to Reduce High Prices and Wide Variations?
- from Part III - Transparency and Economics: Health Care Costs and Billing
-
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp 132-152
-
- Chapter
- Export citation
Acknowledgments
-
- Book:
- Transparency in Health and Health Care in the United States
- Published online:
- 19 June 2019
- Print publication:
- 06 June 2019, pp xv-xvi
-
- Chapter
- Export citation